CREDIT SUISSE AG/ - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$2,913,725
+115.6%
59,198
+59.9%
0.00%
+200.0%
Q4 2023$1,351,194
+74.8%
37,019
+10.7%
0.00%0.0%
Q3 2023$772,902
-35.4%
33,430
-26.7%
0.00%0.0%
Q2 2023$1,196,104
+44.1%
45,618
+41.5%
0.00%0.0%
Q1 2023$829,831
+35.6%
32,239
+37.0%
0.00%0.0%
Q4 2022$612,171
-17.4%
23,536
-9.2%
0.00%0.0%
Q3 2022$741,000
+54.4%
25,928
+32.9%
0.00%
Q2 2022$480,000
-55.1%
19,510
+3.0%
0.00%
-100.0%
Q1 2022$1,068,000
-0.7%
18,944
+9.2%
0.00%0.0%
Q4 2021$1,076,000
+14.6%
17,347
+17.1%
0.00%0.0%
Q3 2021$939,000
-8.4%
14,809
+19.0%
0.00%0.0%
Q2 2021$1,025,000
+3.2%
12,442
-7.8%
0.00%0.0%
Q1 2021$993,000
-61.7%
13,489
-62.3%
0.00%0.0%
Q4 2020$2,593,000
+116.8%
35,753
+42.6%
0.00%0.0%
Q3 2020$1,196,000
+179.4%
25,072
+146.0%
0.00%
Q2 2020$428,000
-27.7%
10,193
-62.7%
0.00%
Q3 2019$592,00027,3190.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 7,281,307$347,100,00032.35%
BVF INC/IL 2,053,991$97,914,0005.33%
Samsara BioCapital, LLC 398,017$18,973,0005.29%
Orbimed Advisors 7,406,307$353,059,0004.44%
Consonance Capital Management LP 602,732$28,732,0003.50%
Boxer Capital, LLC 2,075,905$98,958,0003.42%
Perceptive Advisors 3,481,148$165,946,0002.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,234,262$58,837,0001.43%
DRIEHAUS CAPITAL MANAGEMENT LLC 974,915$46,474,0000.95%
HighVista Strategies LLC 11,477$547,0000.40%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders